Research projects

Omar Khan Team Shot

Active Qatar

Pancreatic cancer

Will stopping a tiny protein improve pancreatic cancer treatment?

Our pancreatic cancer research project in Qatar is investigating a possible new way to improve treatment success for patients. Dr Khan and his team are hoping to make cancer cells more vulnerable to chemotherapy.

Researcher: Dr Omar Khan

Will stopping a tiny protein improve pancreatic cancer treatment?
Antonells Papa Teamshot

Active Australia

Breast cancer

Is a particular mutation driving treatment resistance?

Dr Papa in Australia wants to find a new way to treat breast cancer, that could work in combination with current treatments. This will help tackle treatment resistance. 

Researcher: Dr Antonella Papa

Is a particular mutation driving treatment resistance?
George Zachos Team Photo

Active Greece

General cancer research

Can unravelling tangled DNA be the key to a new cancer cure?

Our innovative project in Greece is investigating a whole new way to stop cancer. Dr George Zachos is doing vital discovery work to understand how DNA changes in cells are linked to cancer to find clues to new cures. 

Researcher: Dr George Zachos

Can unravelling tangled DNA be the key to a new cancer cure?
Kasper Rouschop Headshot

Active Netherlands

General cancer research

Could tailored therapies target cancers with a recycling problem?

Thanks to our Curestarters, Dr Rouschop is exploring a particular cancer cell vulnerability - their inability to recycle. He hopes to create tailored cancer therapies with fewer side effects. 

Researcher: Dr Kasper Rouschop

Could tailored therapies target cancers with a recycling problem?
Edurne Rujas Team

Active Spain

General cancer research

Can ‘2 in 1’ therapy improve how we treat cancer?

Our project in Spain is exploring an innovative new 'dual-action' cancer cure. Immunotherapy and chemotherapy are two cancer treatments - Dr Rujas has the bright idea of combining both therapies to create a new, better treatment for patients. 

Researcher: Dr Edurne Rujas

Can ‘2 in 1’ therapy improve how we treat cancer?
Mika Reinisalo Headshot

Active Finland

Retinoblastoma

Can nanoparticles make a big difference in retinoblastoma cancer?

Curestarter researcher Dr Mika Reinisalo is hoping to find a new way to treat retinoblastoma, a rare but deadly form of eye cancer that affects young children. He is exploring innovative boron therapy that should be kinder to patients. 

Researcher: Dr Mika Reinisalo

Can nanoparticles make a big difference in retinoblastoma cancer?
Luciano Di Croce Team Shot

Active Spain

Brain cancer

Can we find a cure for a rare childhood brain cancer?

Thanks to your help, Professor Luciano Di Croce in Spain is hoping to find a cure for a rare but aggressive type of childhood cancer. 

Researcher: Professor Luciano Di Croce

Can we find a cure for a rare childhood brain cancer?
Helder Maiato Headshot

Active Portugal

Breast cancer

Can we tackle drug resistance by de-coding the structure of cells?

Patients often respond well to chemotherapy only to later develop treatment resistance – meaning the cancer comes back and the chemotherapy has stopped working. Professor Maiato wants to find ways to prevent this treatment resistance.

Researcher: Professor Helder Maiato

Can we tackle drug resistance by de-coding the structure of cells?
Phillip Karpowicz Headshot

Active Canada

Bowel cancer

Does the time we eat affect bowel cancer development?

Dr Karpowicz believes one of the causes of bowel cancer could be that changes to our lifestyle disturb the circadian rhythm of our guts – and with the support of our Curestarters he will be able to test this idea. 

Researcher: Dr Phillip Karpowicz

Does the time we eat affect bowel cancer development?